The transcriptomics market is experiencing strong growth, fueled by increased investments in genomics and personalized medicine. Advancements in next-generation sequencing (NGS) technologies and rising prevalence of chronic diseases have boosted demand for transcriptome analysis. Research institutions and biotech firms are increasingly utilizing transcriptomics for drug discovery, biomarker identification, and disease diagnostics.
Read More: https://www.imarcgroup.com...